Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 899809-64-4 | MDL No. : | MFCD16877199 |
Formula : | C9H11NO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PEYXGOWSKLZBEO-SNAWJCMRSA-N |
M.W : | 197.19 | Pubchem ID : | 44224960 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.44 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 52.19 |
TPSA : | 83.12 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.74 cm/s |
Log Po/w (iLOGP) : | 1.08 |
Log Po/w (XLOGP3) : | 1.07 |
Log Po/w (WLOGP) : | 1.38 |
Log Po/w (MLOGP) : | 0.32 |
Log Po/w (SILICOS-IT) : | -0.76 |
Consensus Log Po/w : | 0.62 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -1.54 |
Solubility : | 5.7 mg/ml ; 0.0289 mol/l |
Class : | Very soluble |
Log S (Ali) : | -2.41 |
Solubility : | 0.772 mg/ml ; 0.00392 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | 0.08 |
Solubility : | 239.0 mg/ml ; 1.21 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 3.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 3.58 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
76.5% | Stage #1: With sodium hydroxide In methanol; water at 5 - 20℃; for 24 h; Stage #2: With acetic acid In methanol; water |
To a solution of 10 (67 g, 432 mmol) in 1 L of methanol at 0 0C was added 144.4 g (432 mmol) of the Wittig reagent. The resulting mixture was agitated at 0 0C for 3 hrs. The solvent was removed under reduced pressure. The residue was extracted with MeOBu -t twice. The extract was filtered to remove any solid, washed with brine, and concentrated. The residue was chromatographed on a silica gel column, eluting with hexane/ethyl acetate (10/ 1) to give 9.2 g cis and 55.1 g (60.4percent) trans product. 1H NMR (CDCl3) d 7.31 (d, J = 11.3 Hz, IH), 6.18 (m, IH), 5.84 (d, J = 15.9 Hz, IH), 4.74-4.68 (m, IH), 3.76 (s, 3H), 2.81-2.74 (m, 2H), 2.50-2.04 (m, 4H).Next, to a flask were added 2.1 g of the methyl ester, 9.6 ml of MeOH and 2.4 ml of water. To the mixture at about 5 0C was added dropwise 0.96 ml of 50percent NaOH. The mixture was allowed to warm to room temperature and stirred at this temperature for about 24 hrs. The reaction mixture was neutralized with HOAc to pH between 4 and 5 and the methanol was removed under reduced pressure. The residue was extracted with 3 X 50 ml EtOAc. The EtOAc layer was concentrated to EPO <DP n="39"/>give 1.5 g of nitroacid 6 (76.5percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | Stage #1: at 60℃; for 7 h; Stage #2: With hydrogenchloride In pyridine; water at 15 - 25℃; |
To a solution of S-nitro-cyclohex-l-enecarbaldehyde (18g, 0.116 mol) in pyridine (36 ml) was added malonic acid (41 g, 0.394 mol). The resulting suspension was heated to 60 0C for about 7 hours. After cooling to a temperature between 150C and 200C, 6N HCl (72 ml) was slowly added into the reaction mixture to adjust the pH to between 1.5 and 2 while maintaining the temperature between 200C and 250C. The mixture was then extracted with methylene chloride three times (1X180 ml, 2X90 ml). The combined extracts were washed with IN HCl (48 ml), water (48 ml) and concentrated to a volume of 36 ml. The concentrate suspension was cooled to O0C and 50C for 1 hour. Light yellow solid was obtained after filtration and drying under vacuum. Yield: 1Og, 60percent. Mp 158-160 0C. IHNMR (400 MHz, DMSOd5): δ 2.10 - 2.33 (m, 4H), 2.73 (m, 2H), 4.96 (m, IH), 5.83 (d, J = 20 Hz, IH), 6.28 (s, IH), 7.27 (d, J = 20 Hz, IH), 12.3 (s, IH). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
98.1 - 98.9 % ee | at 35℃; for 96 h; Enzymatic reaction; Resolution of racemate | The coupling was carried out by the scheme outlined in Example 12. In the coupling, 2.52 g of (VIIId), 4.31 g of (DIb), and 1.2 g of chirazyme L-9 were mixed in 75 ml of dry TBME. The reaction was agitated at 35 0C. After 96 h, the conversion reached 95.4percent, giving approximately 70percent of the product (Ie), and 30percent of the corresponding acid (VIIc). To remove the remaining (IHb), 50 ml iPrOAc and 4.3 g of SO3-Pyr in 5 ml DMF were added to the mixture. The agitation was continued for 2 h to complete the sulfonation. The insoluble was then removed by filtration. The organic solution was washed with 5percent acetic acid, 8percent KHCO3, and brine, 150 ml each. After concentration, the crude oil (2.6 g) was purified over a silica gel column. It gave 2.15 g product (Ie) in >99percent purity. NMR analysis indicated that the product was a mixture of two diastereomers. The ee with the respect of (IHb) moiety was determined to be 98.1percent for R enantiomer. |
[ 95883-10-6 ]
3-(2,5-Dimethylphenyl)acrylic acid
Similarity: 0.54
[ 1734-79-8 ]
3-(4-Nitrophenyl)acrylaldehyde
Similarity: 0.52
[ 39585-32-5 ]
2-(Carboxymethyl)-4-nitrobenzoic acid
Similarity: 0.61
[ 20246-81-5 ]
4,4'-Dinitro-[1,1'-biphenyl]-2,2'-dicarboxylic acid
Similarity: 0.60
[ 39585-32-5 ]
2-(Carboxymethyl)-4-nitrobenzoic acid
Similarity: 0.61
[ 20246-81-5 ]
4,4'-Dinitro-[1,1'-biphenyl]-2,2'-dicarboxylic acid
Similarity: 0.60